Evidence map›Paper›PMID 35861934›Full record

ArticleChemistry (Weinheim an der Bergstrasse, Germany)2022

Multistep Continuous Flow Synthesis of Isolable NH

Michael Andresini, Sébastien Carret, Leonardo Degennaro, Fulvio Ciriaco, Jean-François Poisson, Renzo Luisi

Abstract read
In one paragraph

Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Multistep Continuous Flow Synthesis of Isolable NHChemistry (Weinheim an der Bergstrasse, Germany) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Michael AndresiniFLAME-Lab, Flow Chemistry and Microreactor Technology Laboratory, Department of Pharmacy - Drug Sciences, University of Bari, "A. Moro" Via E. Orabona 4, 70125, Bari, Italy.
Sébastien CarretUniv. Grenoble Alpes, CNRS, DCM, 301 rue de la chimie, 38000, Grenoble, France.
Leonardo DegennaroFLAME-Lab, Flow Chemistry and Microreactor Technology Laboratory, Department of Pharmacy - Drug Sciences, University of Bari, "A. Moro" Via E. Orabona 4, 70125, Bari, Italy.
Fulvio CiriacoDepartment of Chemistry, University of Bari, "A. Moro" Via E. Orabona 4, 70125, Bari, Italy.
Jean-François PoissonUniv. Grenoble Alpes, CNRS, DCM, 301 rue de la chimie, 38000, Grenoble, France.
Renzo LuisiFLAME-Lab, Flow Chemistry and Microreactor Technology Laboratory, Department of Pharmacy - Drug Sciences, University of Bari, "A. Moro" Via E. Orabona 4, 70125, Bari, Italy.ORCID http://orcid.org/0000-0002-9882-7908

Funding

ANR project ketflo ANR-18-CE07-0035-01Dompè SpA CT-2021 unibaEUR-CBH ANR-11-LABX-0003-01University of Bari N. 25308-VIII/2
6 · The paper itself

Abstract

The growing interest in novel sulfur pharmacophores led to recent advances in the synthesis of some S(IV) and S(VI) motifs. However, preparation and isolation of uncommon primary sulfinamidines, the aza-analogues of sulfinamides, is highly desirable. Here we report a multistep continuous flow synthesis of poorly explored NH

Indexed as

BromidesLithiumCelecoxibHalogensIodidesSulfurBromidesCelecoxibHalogensIodidesLithiumSulfurflow chemistryorganolithiumssulfinamidinessustainable chemistrysynthetic methodologies

Identifiers

PMID35861934
PMCPMC9804385

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.